On September 9, 2020 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, reported that HOOKIPA’s management team will participate in the following virtual investor conferences in September (Press release, Hookipa Pharma, SEP 9, 2020, View Source [SID1234564804]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 22nd Annual Global Investment Conference, September 14-16, 2020
Presentation: Monday, September 14, 2020 at 10:30 AM ET

Morgan Stanley Virtual Global Healthcare Conference, September 14-18, 2020
Presentation: Tuesday, September 15, 2020 at 12:30 PM ET

BofA Global Healthcare Conference 2020, September 16-18, 2020
Presentation: Wednesday, September 16, 2020 at 2:10 PM BST
The live audio webcast of the presentation held at the H.C. Wainwright 22nd Annual Global Investment Conference, Morgan Stanley Virtual Global Healthcare Conference and BofA Global Healthcare Conference will be available within the Investors & Media section of HOOKIPA’s website at View Source An archived replay will be accessible for 30 days following the event.